Cargando…
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
SIMPLE SUMMARY: Currently, there is a need for prognostic tools that can stratify patients, who present with primary disease, based on whether they are at low or high risk for drug resistant and hormone-independent lethal metastatic prostate cancer. The aim of our study was to assess the potentially...
Autores principales: | Karkampouna, Sofia, De Filippo, Maria R., Ng, Charlotte K. Y., Klima, Irena, Zoni, Eugenio, Spahn, Martin, Stein, Frank, Haberkant, Per, Thalmann, George N., Kruithof-de Julio, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768471/ https://www.ncbi.nlm.nih.gov/pubmed/33334054 http://dx.doi.org/10.3390/cancers12123786 |
Ejemplares similares
-
Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021) -
Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020) -
Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2021) -
ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models
por: Astrologo, Letizia, et al.
Publicado: (2017) -
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
por: Bonollo, Francesco, et al.
Publicado: (2020)